Chen Shuqin, Jin Yong, Xu Miao, Zhang Pingping, Zhou Ye, Qian Xingjun, Song Qifa, Bu Shizhong, Sun Jing, Li Li
Department of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, Zhejiang Province, People's Republic of China.
Department of Internal Medicine, Ningbo Yinzhou Second Hospital, Ningbo, Zhejiang Province, People's Republic of China.
Diabetes Metab Syndr Obes. 2022 Mar 22;15:887-896. doi: 10.2147/DMSO.S356882. eCollection 2022.
The thyroid hormone has been demonstrated to be associated with nonalcoholic fatty liver disease (NAFLD) in different populations. However, the relationship between thyroid hormone and the degree of liver steatosis in overweight/obese subjects is still unclear. Liver ultra-sound attenuation (LiSA) is a newly developed ultrasound attenuation parameter for the analysis of hepatic steatosis. The study aimed to characterize the relationship between thyroid hormone and LiSA in overweight/obese participants.
This case-control study was performed in Ningbo First Hospital, China. A total of 24 lean, 66 overweight and 49 obese participants were consecutively recruited from January 2021 to May 2021. Thyroid hormone and other clinical features were measured. LiSA was acquired by using a Hepatus ultrasound machine. Multiple linear regression analyses were performed to examine associations of LiSA and clinic indices.
Obese subjects had higher LiSA, fT3 and TSH levels than lean participants of similar age and sex ( < 0.05). LiSA was positively associated with the fT3 level. The multiple linear regression analyses showed that fT3 (ß = 0.353, < 0.001) was independently associated with LiSA in overweight/obese participants.
The fT3 level was independently associated with the degree of liver steatosis among the overweight/obese participants.
甲状腺激素已被证明在不同人群中与非酒精性脂肪性肝病(NAFLD)相关。然而,甲状腺激素与超重/肥胖受试者肝脏脂肪变性程度之间的关系仍不清楚。肝脏超声衰减(LiSA)是一种新开发的用于分析肝脏脂肪变性的超声衰减参数。本研究旨在描述超重/肥胖参与者中甲状腺激素与LiSA之间的关系。
本病例对照研究在中国宁波市第一医院进行。2021年1月至2021年5月连续招募了24名瘦人、66名超重者和49名肥胖参与者。测量甲状腺激素和其他临床特征。使用Hepatus超声仪获取LiSA。进行多元线性回归分析以检验LiSA与临床指标之间的关联。
肥胖受试者的LiSA、游离三碘甲状腺原氨酸(fT3)和促甲状腺激素(TSH)水平高于年龄和性别相似的瘦人参与者(P<0.05)。LiSA与fT3水平呈正相关。多元线性回归分析显示,在超重/肥胖参与者中,fT3(β=0.353,P<0.001)与LiSA独立相关。
在超重/肥胖参与者中,fT3水平与肝脏脂肪变性程度独立相关。